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Reserve cells (RCs) are located in the transformation zone 
of the cervix, under the endocervical columnar epithelium. 
They are thought to give rise to metaplastic squamous cells, 
may “qualify” as stem cells, and play a role in cervical car-
cinogenesis (Martens et al. 2004; Kerdraon et al. 2012). 
Evidence has been presented for the existence of two sub-
populations of RCs, one giving rise to squamous, the other 
to glandular epithelium, and both of which can be differen-
tiated by cytokeratin (CK) immunostaining (Regauer and 
Reich 2007; Martens et al. 2009). Data suggest that RCs 
have specific characteristics; however, their exact nature 
and role in cervical epithelium replacement, in cervical car-
cinogenesis, as well as their possibility of being a target for 
human papilloma virus (HPV) infection have still not been 
clearly clarified (Martens et al. 2004, 2009).
Polarized structure is highly important in epithelial cel-
lular interactions, in both glandular and squamous epithelia 
(Balda and Matter 2008). Intercellular junctional complexes 
composed of tight junctions (TJs), adherens junctions, des-
mosomes, and gap junctions, play a role in epithelial orga-
nization and preservation of tissue integrity.
TJs structurally consist of transmembrane and membrane-
associated proteins. The main constituents of TJ strands are 
a large family of transmembrane proteins—the claudins 
(20–27 kDa) (Tsukita et al. 2008; Furuse 2010)—thought to 
have 24 members (at least in mice and humans), but to 
which three subtypes have been recently added (Mineta et al. 
2011). TJs of different cells are composed of several, highly 
specific claudins and the expression profile of individual 
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Summary
Stem cells participate in cervical carcinogenesis but their function and exact features are still not clear. One type of 
stem-like cells are endocervical reserve cells (RCs), and their association with other normal/altered cervical cells is not 
exactly known. Epithelial cells are attached to each other by tight junctions. Their dominant components are the claudin 
proteins, which show changed expression in cancer; however, no data are available on their pattern. Expressions of various 
claudins (1, 2, 3, 4, 7), occludin, cytokeratins 5/6 and 7, and p63 were analyzed in 60 paraffin-embedded cervical samples. 
Immunohistochemical reactions were evaluated semiquantitatively and statistically. Claudin 1 was as high in RCs as in 
cervical intraepithelial neoplasia (CIN) and higher than in suprabasal squamous epithelial cells, contrary to the negative 
glandular and squamous basal cells. Claudin 2 was positive in all cell types except parabasal cells, whereas claudins 4 and 
7 were weakly positive and claudin 3 was negative in all cell types. Occludin was positive in RCs, basal/parabasal cells, and 
CIN, whereas glandular cells were negative. This is a first report that describes the intermediate claudin pattern of RCs, 
demonstrating that it differs from that of cervical glandular and squamous basal cells, but showing an expression similar to 
the strong claudin 1 expression detected in cervical neoplastic cells. ( J Histochem Cytochem 61:880–888, 2013)
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claudins varies among tissues resulting in a characteristic 
claudin pattern.
Recently, several publications demonstrated alterations 
in the expression of different TJ proteins, the first of clau-
dins in cancer cells. Up- or downregulation of different 
types of claudins has been previously described (for 
reviews, see Morin 2005; Hewitt et al. 2006; Oliveira and 
Morgado-Diaz 2007; Förster 2008; Tsukita et al. 2008; 
Szabó et al. 2009; Singh et al. 2010; Escudero-Esparza et al. 
2011; Soini 2012). Changes in claudin expression during 
carcinogenesis were detected at gene and protein levels, 
suggesting the role of claudins as progression markers in 
several cancers. It was previously observed that the loss of 
TJs occurred in cancer in association with tumor progres-
sion, and a decrease in claudin expression was expected 
during cancer development. In contrast, however, upregula-
tion of several individual claudins, such as claudin 4 in 
cholangiocarcinoma (Lódi et al. 2006), in pancreas carci-
noma (Borka et al. 2007), and in ovarian cancer (for review, 
see Szabó et al. 2009), was observed and found in several 
cases to be associated with patient survival (Korompay et 
al. 2012). Increased claudin 1 expression was detected in 
cervical intraepithelial neoplasia (CIN) and invasive cervi-
cal cancer in our previous study, suggesting that upregula-
tion of certain claudins does not necessarily mean increase 
in “tightness” of TJs but rather a malfunction (Sobel, Páska, 
et al. 2005; Sobel, Szabó, et al. 2005). Altered claudin 
expression has been described in other gynecological 
malignancies too, which besides having diagnostic signifi-
cance, may have therapeutic consequences as well (Lee et 
al. 2005; Sobel et al. 2006; Choi et al. 2007; Gaetje et al. 
2008; Kleinberg et al. 2008; Szabó et al. 2009). From this 
aspect, it might be important to analyze the expression of 
claudins and other TJ proteins, such as occludin, in normal 
and altered cervical cells and endocervical glands in RCs, 
further to compare the expression patterns with other nor-
mal mature and stem-like cervical cells, as well as the 
changes detected in neoplastic cells. The expression pattern 
of claudins might reflect the stage of development or the 
relationship between different cell types. For this reason, 
the current study focuses on a more indepth characterization 
of RCs with the aid of a TJ protein pattern as compared with 
already known markers, in order to better understand their 
role in cervical cellular differentiation and carcinogenesis.
Materials & Methods
Case Selection
A total of 60 cervical samples were studied, obtained from the 
archives of the 2nd Department of Pathology of Semmelweis 
University and Department of Pathology of St. Stephan 
Hospital, Budapest, with the permission of the Regional 
Ethical Committee. Samples were removed for diagnostic or 
therapeutic purposes and included 40 knife cone and loop 
excision samples of cervical intraepithelial neoplasias (CIN 
II–III) and 20 cases of normal cervical tissue (obtained from 
patients with myoma uteri). The samples were previously 
screened for the presence of RCs on hematoxylin-eosin (HE) 
stained slides by expert gynecopathologists (EB, AK).
Histology and Immunohistochemistry
Tissues were fixed in 10% neutral buffered formalin for 24 
hr followed by paraffin embedding, then cut and stained 
using HE to establish a diagnosis.
The formalin-fixed paraffin-embedded (FFPE), 3- to 
4-μm-thick sections were used for immunohistochemistry. 
After deparaffinization, slides were washed in PBS (pH 
7.4) and then microwave oven treated for 3 min with 850 
W, followed by 170 W for 30 min with antigen retrieval 
solution (Target Retrieval Solution; Dako, Glostrup, 
Denmark). Reactions were carried out in Ventana ES auto-
matic immunostainer (Ventana Medical Systems Inc.; 
Tucson, AZ) using avidin-biotin peroxidase technique and 
diaminobenzidine as chromogen according to the manufac-
turer’s protocol (iView DAB Detection Kit; Ventana).
Well characterized primary antibodies against claudins 
(CLDNs) 1, 2, 3, 4, and 7, occludin, CK5/6, CK7, p63, and 
Ki67 were diluted (Table 1) and applied for 30 min at room 
Table 1. Primary Antibodies and Dilutions Used.
Antigen Type Dilution Manufacturer
Claudin 1 mouse monoclonal 1:100 Cell Marque (Rocklin, CA)
Claudin 2 mouse monoclonal 1:20 Invitrogen (Carlsbad, CA)
Claudin 3 rabbit monoclonal 1:80 Invitrogen (Carlsbad, CA)
Claudin 4 mouse monoclonal 1:100 Invitrogen (Carlsbad, CA)
Claudin 7 rabbit monoclonal 1:100 Invitrogen (Carlsbad, CA)
Occludin rabbit monoclonal 1:100 Zymed (San Francisco, CA)
Cytokeratin 5/6 mouse monoclonal 1:600 Dako (Glostrup, Denmark)
Cytokeratin 7 mouse monoclonal 1:2000 Dako (Glostrup, Denmark)
p63 mouse monoclonal 1:100 Izinta (Budapest, Hungary)
Ki67 mouse monoclonal 1:100 Dako (Glostrup, Denmark)
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temperature in the Ventana immunostainer. For negative 
controls, the specific antibodies were omitted and either the 
antibody diluent was used alone or isotype-matched IgG 
serum. Tissues recommended by manufacturers were used 
as positive controls.
Evaluation and Statistical Analysis
Distribution, intensity, and subcellular localization (mem-
branous, cytoplasmic, nuclear) of the immunostainings 
were recorded. Semiquantitative evaluation was applied for 
immunoreactions, analyzing five randomly selected areas 
per slide using ×40 objective and counting 100 cells in each 
field (Olympus BX50 microscope; Olympus Corporation, 
Tokyo, Japan). Scoring of cells showing positive immuno-
reaction was as follows: 0: ≤5%, 1: 6% to 30%, 2: 31% to 
60%, and 3: 61% to 100%. Intensity was scored as 1 = 
weak, 2 = moderate, and 3 = strong staining reaction. A 
summary score multiplying percentage and intensity scores 
was created for each slide.
Kruskal-Wallis test was used to compare the expres-
sion of individual claudins and occludin detected by 
immunohistochemistry in the different groups. Two val-
ues were considered significantly different at p<0.05.
Immunoreactions for CK 5/6, CK7, and p63 were used 
to characterize RCs as described previously and for Ki67 to 
evaluate the rate of proliferation.
Results
Immunohistochemistry
RCs were identified by HE staining along the columnar glan-
dular cells (Fig. 1A) and identified further by CK5/6 (Fig. 
1B), CK7 (Fig. 1D), and p63 (Fig. 1C) immunoreactions.
In normal cervical squamous epithelia, the expression of 
individual claudins and occludin was recognized in the 
same localization and distribution as described previously. 
Parabasal squamous epithelial cells expressed CLDNs1 
(Fig. 2A), 4, and 7 (not shown) and occludin in membra-
nous localization with moderate intensity (the latter two not 
shown), whereas the upper layers stained much less inten-
sively or were negative. Contrarily, squamous basal cells 
were negative for CLDN1 (Fig. 2A) but positive for 
Figure 1. Reserve cells (arrows) located alongside cervical glandular cells as seen by hematoxylin-eosin staining (A) and by 
immunohistochemical reactions using antibodies against cytokeratin (CK) 5/6 (B), p63 (C), and CK7 (D). Bars = 50 μm.
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occludin (Fig. 3A) and CLDN2 (Fig. 3C) and stained 
weakly for CLDNs4 and 7 (not shown).
Cervical columnar glandular cells were negative for 
CLDN1 (Fig. 2B), CLDN3, and occludin (Fig. 3B), positive 
for CLDN2 (Fig. 3C), and less intensively stained for 
CLDNs4 and 7 (not shown).
Endocervical RCs located along the columnar glandular 
cells facing the stroma (Fig. 1A) expressed CLDN1 (Figs. 
2B, C, D) and CLDN2 (Fig. 3D) intensively and showed no 
CLDN3 and only weak CLND4 and CLDN7 expression (not 
shown). Occludin was detected in RCs, as well (Fig. 3B).
Strong CLDN1 expression was seen in CIN (Fig. 2B) as 
described earlier, with similar intensity as in the endocervi-
cal RCs.
Statistical Analysis
Claudin pattern in parabasal and basal cells of normal squa-
mous epithelial cells, cervical glands, squamous metaplasia, 
and RCs differed significantly (Table 2). CLDN1 was nota-
bly higher in RCs than in glandular cells and squamous basal 
cells, and the latter two were found to be negative (Fig. 4). 
CLDN1 reaction in RCs was even higher than in the para-
basal layer of squamous epithelia (p<0.0001); however, no 
differences were found in comparison to CIN lesions. In 
contrast, CLDN2 was high in columnar glandular cells, in 
basal cells of the squamous epithelia, and in RCs, with no 
significant differences observable. Parabasal squamous epi-
thelial cells gave a reaction of lower intensity (Fig. 4). 
CLDN3 was negative in all cell types. CLDN4 gave a weak 
reaction, not differing significantly in the studied normal 
cell types. CLDN7 was positive in parabasal cells and RCs 
and negative in basal and columnar glandular cells (Fig. 4).
Comparing the claudin pattern of the different cell types, 
RCs and CIN lesions showed similar characteristics in 
expression of individual claudins (Fig. 5), whereas the char-
acteristics of columnar epithelial cells were more similar to 
squamous basal cells at least in the expression of CLDNs1, 
2, and 7 but were different regarding occludin (Fig. 5).
Discussion
The endocervical canal is lined by columnar mucin-containing 
cells with villous processes, crypts, and tunnels, the latter 
Figure 2. Claudin 1 membranous immunoreaction in parabasal squamous epithelial cells is positive (A) (arrow) and negative in basal 
cells. The reserve cells are strongly positive (B, C, D) (arrows). Cervical intraepithelial neoplasia III is highly positive for claudin 1 (B) 
(asterisk). Bars = 50 μm.
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referred to as glands (Malpica and Robboy 2009). The tran-
sitional, transformation zone between glandular and squa-
mous epithelium of the endocervix is of special significance 
owing to its involvement in cervical alterations, mainly in 
squamous metaplasia, intraepithelial, and invasive cervical 
neoplasias.
Based on morphological and immunohistochemical 
studies, endocervical subcolumnar RCs were suggested as a 
potentional candidate for stem cells (Martens et al. 2004; 
Mak et al. 2012). Previous studies demonstrated the charac-
teristic keratin pattern of RCs (Smedts et al. 1992; Martens 
et al. 2004, 2009; Kerdraon et al. 2012) and presented two 
subpopulations of these cells, one suggested to give rise to 
squamous, the other to glandular epithelium (Martens et al. 
2009). Endocervical RCs showed strong expression for p63 
and cytokeratins 5 and 7 and moderate expression for bcl-2 
(Martens et al. 2009). There was, however, a difference in 
CK17 expression, which was strong in RCs closer to the 
squamo-columnar junction and less pronounced in the area 
closer to the endometrium (Martens et al. 2009). Kerdraon 
et al. (2012) specified the keratin profile of RCs as 
“intermediate” between squamous epithelium expressing 
high molecular-weight keratins (such as 4, 5, 6, 13, 14, and 
17) and columnar epithelium expressing low molecular-
weight keratins (such as 7, 8, 18, and 19).
Our study revealed differences in the expression of 
claudins between RCs and columnar and squamous epithe-
lial cells, the RCs being intermediate as suggested by 
Kerdraon et al. (2012) for the keratin expression pattern. 
RCs expressed CLDN1 strongly, which was detected to a 
lesser degree in parabasal squamous cells and was found 
overexpressed in CIN (Sobel, Páska, et al. 2005; Sobel, 
Szabó, et al. 2005). The intensity of CLDN1 reaction in 
RCs was as high as previously found in CIN lesions (Sobel, 
Páska, et al. 2005; Sobel, Szabó, et al. 2005). In contrast, 
no CLDN1 was detected in the columnar glandular cells. 
On the other hand, RCs expressed CLDN2 with the same 
intensity as columnar epithelial cells and basal cells of 
squamous epithelium. These data support the notion that 
RCs “have a tendency towards bidirectional differentia-
tion” as mentioned by Witkiewicz et al. (2005) for the 
keratin pattern of RCs.
Figure 3. Occludin (A, B) and claudin 2 (C, D) immunoreactions. The squamous epithelial basal cells (A) and reserve cells (B) are 
positive for occludin (arrows), whereas the columnar epithelial cells are negative (B). Claudin 2 is positive in squamous basal cells (C), 
in columnar glandular cells (D), and in reserve cells (D) (arrows). No differences are observable in the intensity of immunoreaction in 
claudin 2 between glandular and reserve cells (D). Bars = 50 μm.
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P63 is expressed in cervical stem cell populations, in 
the basal cells of the ectocervical squamous epithelium, 
and in the endocervical subcolumnar RCs (Martens et al. 
2004). In contrast, we could demonstrate only CLDN1 in 
the RCs, similar to CK17, which was found expressed 
only in RCs and not in basal cells by Martens et al. 
(2004).
Our data show that RCs are a distinct type of cell, with 
a TJ composition that differs from both the squamous and 
glandular epithelium. RCs have unique characteristics in 
the TJ pattern, expressing the highest CLDN1 among all 
normal epithelial cell types of the cervical epithelia, as 
high as in dysplastic cells in CIN lesions. This suggests a 
possible connection between the overexpression of 
CLDN1 during cervical carcinogenesis and the high 
expression of CLDN1 in RCs having stem-like cell 
characteristics.
Tight junctions are made up of a multi-gene protein fam-
ily, the CLDNs (with 27 known subtypes currently), occlu-
din, tricellulin, and so on (Tsukita et al. 2008). Epithelial 
cells and tissues have a highly characteristic CLDN pattern, 
composed of strictly confined individual CLDNs and other 
proteins forming the TJ strands (Mineta 2011). For exam-
ple, CLDN4 is highly expressed in cholangiocytes, whereas 
no (or only low) expression is detected in hepatocytes (Lódi 
et al. 2006). A dynamic model of TJs has been created with 
the suggestion that a continuous remodeling of TJs occurs 
even during normal cell cycles, providing function of junc-
tional complexes, which might mean polymerization of 
claudins with other components (Tsukita et al. 2008). 
During cellular differentiation or dedifferentiation, the 
CLDN pattern changes characteristically in association 
with the functional needs. For example, CLDN1 cannot be 
demonstrated in basal cells of the squamous epithelium but 
can be detected in normal suprabasal squamous epithelial 
cells; this shows that, during maturation, the TJs are remod-
eled and the morphological appearance of the cells has 
changed together with TJ structure and function. However, 
there is no clear explanation for the overexpression of 
CLDN1 in CINl lesions and invasive squamous cell 
Table 2. Results of Immunohistochemical Scoring and Statistical Comparison of Individual Groups According to Proteins.
p Value
 Median IQR K-W Test vs. COL vs. SQU BAS vs. SQU PAR vs. CIN
Claudin 1 RC 9 2.25 <0.001* <0.0001* <0.0001* <0.0001* 1.0000
 COL 0 0.00 1.0000 <0.0001* <0.0001*
 SQU BAS 0 0.00 <0.0001* <0.0001*
 SQU PAR 4 2.50 <0.0001*
 CIN 9 3.00  
Claudin 2 RC 4 3.00 <0.001* 1.0000 1.0000 <0.0001* 1.0000
 COL 4 2.00 0.8372 <0.0001* 1.0000
 SQU BAS 4 1.00 <0.0001* 1.0000
 SQU PAR 2 1.00 <0.0001*
 CIN 4 2.50  
Claudin 4 RC 2 2.00 0.0488 1.0000 1.0000 1.0000 1.0000
 COL 2 1.75 1.0000 1.0000 1.0000
 SQU BAS 1 3.00 1.0000 0.0622
 SQU PAR 1.5 2.00 0.1681
 CIN 2.5 1.75  
Claudin 7 RC 4 2.00 <0.001* <0.0001* <0.0001* 0.0765 1.0000
 COL 1 0.75 0.0012* 0.0043* <0.0001*
 SQU BAS 0 0.00 <0.0001* <0.0001*
 SQU PAR 2 2.75 0.0714
 CIN 4 1.75  
Occludin RC 6 2.00 <0.001* <0.0001* 0.1309 <0.0001* 1.0000
 COL 0 0.00 <0.0001* <0.0001* <0.0001*
 SQU BAS 4 3.00 0.0001* 0.1439
 SQU PAR 2 1.00 <0.0001*
 CIN 6 1.50  
Median and interquartile range values of immunohistochemical scoring are listed. Statistical comparison of horizontal versus vertical groups was 
performed using the Kruskal-Wallis test. Significant differences (p<0.05) are marked by asterisks. IQR, interquartile range (3 quartile–1 quartile); K-W 
Test, Kruskal-Wallis test; RC, reserve cell; COL, columnar glandular cell; SQU BAS, squamous basal cell; SQU PAR, squamous parabasal cell; CIN, 
cervical intraepithelial neoplasia.
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carcinomas and other cancers (Morin 2005; Sobel et al. 
2005). There are data suggesting that an increase or upregu-
lation of individual CLDNs in TJs does not mean that an 
those TJs are “tighter” or function better (Turksen and 
Troy 2011). It shows only that the proportion of the differ-
ent protein components has changed with the probability 
of dysfunction of TJs, such as paracellular barrier func-
tions, selective permeabilities, and altered cellular signal-
ing pathways that are associated with TJ alterations 
(Mineta 2011). The assumption that cancer cells lose their 
TJs and are associated with dyscohesion might be true for 
the morphological appearance but not for the proportion 
of the protein components.
The role and significance of stem/progenitor cells in 
gynecological malignancies are not clear. Basal cells and 
RCs are thought to be stem or progenitor cells in the cer-
vix, the main function of which is to maintain tissue integ-
rity in the normal cervix (Mak et al. 2012). During cervical 
cancer development, however, stem cells might partici-
pate in carcinogenesis. Despite this, the characteristics of 
normal and cancer stem cells in the cervix have not been 
well described yet. To understand the changes in TJ com-
position, the mechanism of remodeling of individual 
proteins that compose the TJ strands of RCs might help to 
better clarify changes that could be associated with cancer 
development.
Further investigations are needed to determine 
whether the increased CLDN1 expression in dysplastic 
cervical cells, even in the early stages of carcinogenesis, 
is a sign of dedifferentiation. These studies would also 
promote our attempts to gain more insight into the “stem-
ness” characteristics or expansion of the stem cell 
compartment.
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Figure 4. Results of immunohistochemistry scoring regarding claudin and occludin patterns among the different cervical cell types. The 
expression of claudin 1 (CLDN-1) is high in reserve cells (RC) and cervical intraepithelial neoplasia (CIN) and is negative in columnar 
glandular and basal cells. Median (symbol) and interquartile ranges are plotted. The links represent significant differences. COL, columnar 
glandular cell; SQU BAS, squamous basal cell; SQU PAR, squamous parabasal cell.
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